lf
format
versatil
manufactur
rapid
immunoassay
test
develop
lf
test
almost
situat
rapid
test
requir
hospit
clinic
physician
offic
clinic
laboratori
lfbase
test
use
qualit
quantit
detect
wide
varieti
antigen
antibodi
recent
develop
measur
product
gene
amplif
use
test
biolog
sampl
includ
urin
tear
sweat
saliva
serum
plasma
whole
blood
biopsi
tissu
fluid
lfbase
test
also
use
veterinari
medicin
qualiti
control
assur
product
safeti
food
product
environment
test
water
safeti
pharmaceut
biolog
manufactur
circumst
rapid
test
use
screen
pathogen
toxin
raw
materi
manufactur
environ
finish
product
water
util
test
drink
water
chemic
toxin
metal
pathogen
rapid
test
system
also
use
assess
progress
environment
remedi
soil
ground
water
pollut
veterinarian
use
rapid
test
screen
commerci
livestock
household
pet
number
medic
condit
anoth
reason
continu
popular
lf
test
low
develop
cost
eas
product
target
analyt
necessari
antibodi
avail
assay
develop
cost
low
higher
prototyp
test
kit
avail
clinic
trial
littl
month
develop
test
test
kit
manufactur
per
test
remaind
chapter
describ
world
market
rapid
immunoassay
lf
test
discuss
progress
lf
test
made
immunoassay
test
segment
chapter
address
impact
patent
new
technolog
futur
lfbase
test
world
market
lfbase
test
estim
million
compound
annual
growth
rate
cagr
reach
million
tabl
estim
includ
lfbase
test
use
human
veterinari
medicin
food
beverag
manufactur
pharmaceut
medic
biolog
person
care
product
product
environment
remedi
water
util
lf
test
also
avail
develop
biowarfar
agent
pathogen
anthrax
smallpox
avian
influenza
potenti
biolog
weapon
includ
market
analysi
test
routin
use
time
fact
market
wait
mode
growth
lf
test
deriv
mainli
clinic
veterinari
sector
current
test
menu
use
place
outsid
central
laboratori
respons
increas
interest
public
health
issu
preval
chronic
diseas
sinc
earli
clinic
lf
test
grown
popular
predict
patient
selftest
skyrocket
rise
consum
expect
technolog
innov
surg
consum
activ
healthcar
furthermor
pharmaci
retail
outlet
physician
offic
establish
posit
patient
well
screen
expect
condit
pointofcar
poc
test
selftest
profession
grow
per
year
instead
predict
howev
may
case
wish
think
realiti
current
test
technolog
accommod
need
consum
profession
market
consum
selftest
mani
test
bloodbas
userfriendli
sampl
type
thu
manufactur
begun
search
altern
sampl
urin
saliva
profession
set
poc
test
meet
qualiti
standard
offer
laboratorybas
test
thought
new
test
technolog
expens
faster
sensit
userfriendli
less
expens
test
may
produc
better
market
penetr
gener
speak
shown
tabl
lf
test
far
limit
success
penetr
market
immunoassay
worldwid
even
clinic
lf
test
manag
market
share
compar
labbas
immunoassay
counterpart
technolog
issu
discuss
part
reason
main
issu
compet
establish
labbas
test
strategi
sensit
less
expens
direct
materi
cost
consid
worldwid
huge
demand
decentr
rapid
test
us
market
account
million
european
market
approxim
million
rest
world
row
remain
tabl
european
union
eu
singl
market
confeder
countri
purpos
discuss
includ
origin
eu
countri
austria
belgium
finland
franc
germani
greec
ireland
itali
luxembourg
netherland
portug
spain
uk
largest
singl
market
rapid
test
product
unit
state
enorm
impact
rapid
test
industri
develop
healthcar
food
safeti
biolog
manufactur
pressur
cost
qualiti
manag
push
need
rapid
decentr
test
howev
even
unit
state
poc
lf
particular
far
live
expect
aspect
lf
technolog
discuss
detail
later
flow
test
use
veterinari
medicin
test
commerci
livestock
larg
anim
cow
poultri
sheep
pig
etc
household
pet
cat
dog
etc
varieti
medic
condit
includ
bacteri
viral
infect
allergi
fertil
issu
diabet
test
segment
confus
food
safeti
test
normal
perform
anim
enter
food
chain
approxim
immunoassay
small
larg
anim
perform
refer
laboratori
lftype
test
occupi
veterinari
rapid
immunoassay
elisa
test
perform
test
gener
revenu
million
worldwid
cagr
reach
million
howev
larg
anim
veterinarian
expect
contain
outbreak
infecti
diseas
livestock
begin
reli
newer
lf
test
rapid
test
result
area
small
anim
veterinari
practic
rapid
onsit
test
provid
signific
advantag
extrem
competit
market
case
anim
owner
pay
test
outofpocket
test
larg
anim
segment
somewhat
regul
ministri
food
agricultur
small
anim
segment
total
nonregul
market
highli
fragment
differ
test
use
specif
anim
speci
lf
veterinarian
market
occupi
test
household
pet
test
includ
test
anemia
cancer
endocrin
function
viral
pathogen
canin
adenoviru
caliciviru
cacv
adenoviru
coronaviru
parvoviru
rabi
rotaviru
west
nile
viru
etc
bacteria
parasit
e
coli
cryptosporidia
heartworm
hookworm
leishmania
leptospirosi
lyme
diseas
roundworm
tapeworm
one
compani
domin
market
lf
test
veterinari
medicin
past
year
food
safeti
issu
concern
public
health
led
stringent
legisl
food
safeti
requir
legisl
produc
increas
demand
pathogen
toxin
test
everi
segment
food
product
industri
process
food
meat
poultri
beverag
dairi
major
food
produc
worldwid
food
safeti
test
perform
use
labbas
tradit
microbiolog
techniqu
appreci
rapid
onthespot
test
rise
test
use
primarili
test
raw
materi
interim
product
manufactur
process
final
product
bacteria
listeria
salmonella
e
coli
other
tradit
microbiolog
test
requir
finish
product
sit
warehous
pend
test
result
take
two
four
day
wherea
rapid
technolog
provid
microbi
test
result
littl
hour
financi
benefit
rapid
microbi
test
method
necess
today
competit
environ
food
beverag
sector
food
largest
segment
within
industri
rapid
test
market
lfbase
test
gener
million
cagr
reach
million
howev
lf
test
food
beverag
test
account
immunoassay
use
sector
see
tabl
grow
demand
food
compani
quicker
test
releas
finish
good
quickli
thu
reduc
inventori
despit
potenti
save
inventori
wareh
cost
lf
test
account
small
share
total
number
food
microbiolog
test
test
use
food
safeti
highli
regul
regulatori
bodi
establish
formal
rapid
test
certif
procedur
europ
denmark
danish
system
valid
microbiolog
test
method
call
danval
franc
associ
francais
de
normalis
afnor
establish
product
approv
associ
analyt
commun
aoac
approv
test
unit
state
driver
demand
rapid
lf
test
food
product
adopt
hazard
analysi
critic
control
point
haacp
regul
prescrib
test
procedur
throughout
manufactur
process
combin
increas
competit
within
european
food
industri
launch
european
valid
system
microv
altern
food
test
method
make
possibl
europ
within
next
year
catch
lead
posit
unit
state
use
rapid
food
test
method
addit
larg
food
export
countri
mexico
brazil
well
grow
process
food
industri
asia
pacif
provid
anoth
avenu
growth
rapid
test
move
facilit
lf
test
use
onsit
smaller
lowvolum
facil
alreadi
immunoassay
instrument
manufactur
market
pregnanc
testlik
immunoassay
dipstick
salmonella
listeria
e
coli
similar
food
industri
product
safeti
major
concern
product
pharmaceut
medic
biolog
person
care
product
known
pharma
specif
regulatori
bodi
overse
steril
pharma
product
howev
pathogen
toxin
content
impact
product
qualiti
detract
compani
brand
imag
eventu
profit
earn
potenti
thu
pharma
product
compani
quick
recogn
contribut
rapid
lf
test
make
bottom
line
pharma
product
manufactur
long
shelflif
sometim
year
may
contamin
slowgrow
bacteria
yeast
mold
may
littl
consequ
earli
product
shelflif
destroy
product
qualiti
grown
unfortun
pharmaceut
industri
gener
hesit
introduc
innov
system
manufactur
sector
lf
test
manag
captur
market
immunoassay
sector
see
tabl
main
reason
regulatori
imper
test
situat
may
soon
chang
due
food
drug
administr
sponsorship
voluntari
regulatori
process
fda
issu
guidanc
document
intend
describ
regulatori
framework
process
analyt
technolog
pat
encourag
voluntari
develop
implement
new
qualiti
assur
procedur
guidanc
prepar
offic
pharmaceut
scienc
center
drug
evalu
research
cder
direct
fda
process
analyt
technolog
pat
steer
committe
membership
cder
center
veterinari
medicin
cvm
offic
regulatori
affair
ora
similar
haacp
pat
intend
system
design
analyz
control
manufactur
time
measur
critic
qualiti
perform
attribut
throughout
manufactur
processfrom
raw
materi
final
product
one
compani
domin
market
lf
pharma
test
leader
strateg
diagnost
neogen
idexx
lab
biocontrol
system
compani
includ
celsi
intern
plc
medic
wire
equip
co
merck
kgaa
mtech
diagnost
ltd
environment
remedi
drink
water
qualiti
highli
regul
govern
agenc
develop
countri
prosper
develop
countri
agenc
epa
fda
food
safeti
inspect
servic
us
depart
agricultur
test
environment
sampl
togeth
associ
offici
analyt
chemist
intern
aoac
establish
offici
method
use
test
environment
contamin
certain
market
segment
aoac
also
manag
procedur
guidelin
valid
new
method
worldwid
throughout
oecd
countri
enact
safe
water
legisl
eu
direct
us
safe
drink
water
act
regul
differ
countri
countri
overal
expect
minim
water
contamin
industri
regul
point
sourc
discharg
pollut
lake
river
signific
impact
contamin
public
health
test
therefor
perform
certifi
laboratori
approv
method
lf
rapid
test
perform
primarili
spot
check
requir
test
period
also
use
household
verifi
cleanli
well
water
small
market
togeth
account
million
worldwid
area
lf
rapid
test
gener
grow
annual
forese
futur
biggest
lf
test
segment
gener
seen
lucr
worldwid
huge
demand
decentr
avail
diagnost
test
clinic
lfbase
rapid
test
gener
compani
revenu
million
account
total
world
market
later
flow
test
tabl
cagr
segment
grow
million
clinic
lf
test
use
primarili
replac
labbas
immunoassay
decentr
test
locat
gener
known
pointofcar
test
poc
data
present
includ
lfbase
poc
immunoassay
selftest
sold
counter
otc
perform
healthcar
profession
hospit
laboratori
hospit
ward
clinic
commun
health
center
physician
offic
data
includ
diabet
segment
test
use
lf
technolog
lf
test
sometim
use
laboratori
rapid
test
result
requir
howev
success
lf
growth
larg
relat
signific
increas
otc
pregnanc
test
variou
profession
test
segment
includ
cholesterol
cardiac
marker
other
shown
tabl
sinc
earli
industri
watchdog
predict
poc
would
domin
methodolog
use
rapid
diagnos
requir
predict
realiz
infrastructur
reimburs
barrier
blame
poc
test
poor
track
record
howev
worldwid
payer
group
begun
provid
reimburs
approv
poc
test
mani
physician
use
poc
test
tool
provid
improv
patient
care
insid
hospit
problem
associ
qualiti
control
train
nonlaboratori
staff
scare
mani
would
user
avoid
issu
mani
hospit
place
rapid
test
system
laboratori
set
special
poc
test
team
therefor
mani
administr
issu
control
tell
caus
poc
limit
market
penetr
realli
technolog
rapid
poc
test
base
immunochromatograph
techniqu
visual
detect
test
result
howev
imag
comput
capabl
improv
signific
trend
within
diagnost
industri
replac
visual
detect
digit
instrumentbas
method
new
poc
test
devic
builtin
memori
store
test
result
later
download
comput
abil
send
result
receiv
network
design
multitest
cassett
avoid
need
qualiti
control
procedur
time
test
run
improv
aspect
poc
test
gone
long
way
increas
test
profession
sector
next
step
make
home
test
chronic
diseas
interact
patient
advis
take
action
necessari
similarli
poc
inform
system
aid
physician
determin
signific
lab
result
valuead
compon
poc
test
progress
wide
use
home
counter
otc
lf
test
pregnanc
ovul
worldwid
home
test
gener
approxim
million
market
otc
test
homebas
test
drug
use
limit
appeal
parent
primarili
unit
state
test
cholesterol
infecti
diseas
fecal
occult
blood
coagul
anticip
market
penetr
manufactur
anticip
consum
accept
selftest
need
blood
sampl
primari
reason
limit
use
test
ad
signific
dilemma
user
selftest
mean
consum
often
confus
test
result
prefer
time
ripe
userfriendli
digit
otc
devic
leav
noth
interpret
launch
otc
pregnanc
test
devic
say
ye
instead
seri
line
dot
public
readi
manufactur
meantim
latest
trend
overcom
retic
selftest
direct
consum
market
lab
test
public
venu
mall
supermarket
home
test
kit
via
internet
mani
year
slow
growth
profession
poc
test
market
begin
come
aliv
demand
quicker
test
turnaround
time
spur
launch
least
new
poc
test
devic
past
year
least
anoth
near
market
market
profession
lf
poc
test
estim
million
approxim
million
growth
market
segment
reach
million
growth
come
increas
use
cardiac
marker
test
critic
care
growth
stem
new
assay
cancer
diabet
cardiac
diseas
lipid
coagul
factor
poc
test
need
fill
lftype
rapid
test
increasingli
physician
look
increas
number
test
offer
offic
grow
demand
small
easytous
easytomaintain
system
nearpati
site
small
clinic
lab
worldwid
hospit
set
pressur
rapid
turnaround
time
effici
patient
manag
minim
length
stay
emerg
room
throughout
hospit
howev
hospit
administr
maintain
poc
test
lf
includ
expens
labbas
test
manual
read
patient
test
result
lost
histor
record
patient
leav
acut
care
area
er
intens
care
unit
baselin
test
done
unit
rel
useless
often
test
result
lf
devic
correl
well
labbas
system
evid
supplydemand
dynam
evid
continu
growth
market
critic
care
analyz
instrument
system
cardiac
cancer
marker
outsid
hospit
wide
use
profession
poc
test
pregnanc
infecti
diseas
cholesterol
urinalysi
strip
europ
numer
compani
market
small
tabletop
chemistri
immunoassay
system
physician
offic
lab
pol
clinic
unit
state
trend
emerg
number
year
pol
resort
perform
clinic
laboratori
improv
amend
clia
waiv
test
howev
past
sever
year
compani
begun
distribut
chemistri
hematolog
immunoassay
instrument
pol
aggress
compet
significantli
lf
test
especi
area
infecti
diseas
cardiac
marker
cholesterol
hormon
test
anticip
rapid
test
h
pylori
strep
flu
cholesterol
lyme
diseas
sexual
transmit
diseas
std
eg
chlamydia
vagin
would
becom
part
physician
care
routin
case
although
least
vendor
worldwid
market
poc
test
kit
analyt
number
reason
account
limit
use
test
worldwid
firstli
test
take
long
patient
wait
approxim
min
test
result
may
alreadi
spent
least
long
wait
turn
see
physician
technolog
mani
test
prove
sensit
labbas
test
futur
use
miniatur
labonachip
type
devic
make
rapid
costeffect
assay
assay
avail
pol
use
expect
make
market
impact
lf
market
highli
diversifi
differ
set
compani
activ
variou
sector
least
compani
activ
largest
selftest
segment
pregnanc
ovul
nj
major
pharmaci
chain
sell
home
brand
test
kit
manufactur
leader
origin
equip
manufactur
oem
compani
test
segment
continu
grow
averag
per
year
women
enjoy
use
test
privaci
home
roch
diagnost
indianapoli
pioneer
coagul
selftest
market
sinc
success
europ
primarili
germani
howev
without
reimburs
littl
demand
unit
state
juli
us
medicar
program
began
cover
home
anticoagul
monitor
patient
mechan
heart
valv
take
coumadin
segment
therefor
see
annual
growth
past
sever
year
sever
poc
pregnanc
test
pt
come
market
use
profession
hospit
clinic
set
mani
pharmaci
maintain
clia
lab
alreadi
prepar
offer
pt
test
patient
unabl
perform
test
payment
arrang
health
insur
provid
qualifi
patient
would
paid
outofpocket
profession
cholesterol
test
take
place
outsid
hospit
patient
care
site
physician
offic
clinic
well
fair
market
grow
healthi
annual
estim
million
market
leader
roch
accuchek
reflotron
product
invernesscholestech
ldx
player
actim
laboratori
burlington
nj
enact
total
cholesterol
test
johnson
johnson
advanc
care
cholesterol
test
polym
technolog
system
inc
indianapoli
bioscann
test
strip
learn
cardiovascular
diseas
link
diabet
lipid
metabol
inflamm
hypercoagulopathi
definit
cardiac
marker
expand
depend
one
point
view
test
ddimer
hscrp
highsensit
c
reactiv
protein
cholesterol
associ
lipid
fraction
consid
part
cardiac
marker
segment
thu
far
dynam
poc
segment
show
chang
next
year
particularli
assembl
multianalyt
panel
draw
area
meantim
tradit
cardiac
marker
ckmb
myoglobin
troponin
shake
emerg
ddimer
hscrp
bnp
btype
natriuret
peptid
new
addit
undisput
leader
innov
segment
biosit
inc
part
inver
medic
also
least
compani
sell
lf
test
one
cardiac
marker
panel
least
compani
sell
rapid
test
infecti
diseas
includ
strep
ab
legionella
hbsag
test
mononucleosi
malaria
respiratori
virus
influenza
mening
filariasi
adenoviru
tuberculosi
epstein
barr
viru
measl
mump
rubella
chlamydia
gonorrhea
primari
market
lfbase
infecti
diseas
test
patient
care
set
outsid
hospit
market
leader
inver
medic
market
sector
see
moder
cagr
due
increas
test
respiratori
diseas
pathogen
howev
rapid
immunoassay
threaten
breakthrough
molecular
test
increas
sensit
specif
test
cancer
test
done
labbas
immunoassay
molecular
test
analysi
tissu
biopsi
newest
lf
test
market
inver
matritech
bladderchek
test
poc
test
bladder
cancer
june
matritech
report
one
million
bladderchek
test
sold
product
account
approxim
compani
product
sale
million
us
market
account
million
european
market
approxim
million
worldwid
market
lf
clinic
test
japan
asia
repres
million
row
account
remain
market
largest
singl
market
vitro
diagnost
ivd
poc
product
unit
state
enorm
impact
rapid
test
industri
develop
manag
care
obsess
cost
reduct
push
need
nearer
patient
decentr
test
home
bedsid
physician
offic
impli
level
connect
gener
avail
current
poc
devic
becom
necessari
featur
new
product
design
european
market
poc
test
especi
pol
sector
grow
faster
unit
state
howev
test
locat
use
low
volum
tabletop
version
tradit
chemistri
immunoassay
hematolog
instrument
versu
special
design
poc
devic
main
reason
laboratori
lightli
regul
compar
clia
standard
requir
unit
state
therefor
european
market
lfbase
devic
evolv
slower
unit
state
situat
may
chang
eu
govern
see
central
test
way
control
cost
deliv
healthcar
age
popul
similar
countri
oecd
organ
econom
cooper
develop
begun
place
greater
emphasi
predict
prevent
diseas
proactiv
diagnost
thu
poc
test
market
europ
expect
increas
number
test
conduct
number
test
avail
number
test
locat
japan
highli
central
form
healthcar
deliveri
leav
much
room
poc
test
physician
offic
howev
japan
hospit
increas
uptak
rapid
test
emerg
critic
care
japan
singl
largest
market
rapid
flu
test
sinc
roch
tamiflu
prescrib
diagnos
case
influenza
combin
increas
intern
demand
sophist
laboratori
system
qualiti
rapid
test
product
conjunct
slow
ivd
market
growth
oecd
countri
encourag
compani
look
outsid
tradit
market
unit
state
europ
japan
market
opportun
evolv
emerg
market
south
america
eastern
europ
russia
part
asia
africa
entrepreneuri
compani
begin
take
advantag
method
surviv
altruist
reason
root
later
flow
technolog
go
back
discoveri
antibodyantigen
immunoassay
reaction
yallow
burson
combin
principl
thin
layer
paper
chromatographi
within
sever
month
three
research
robert
rosenstein
becton
dickinson
co
keith
may
unilev
david
charlton
carter
wallac
file
us
patent
consid
basic
lf
platform
bd
still
own
rosenstein
patent
inver
medic
acquir
two
patent
interview
robert
rosenstein
explain
three
patent
essenti
thing
slight
variat
aim
develop
easi
otc
platform
pregnanc
test
signific
implic
almost
simultan
file
took
year
patent
issu
ten
year
delay
imped
innov
time
demand
rapid
test
expand
result
recent
lf
test
analyt
technolog
ad
patent
delay
imped
innov
rapid
test
patent
prevent
competit
encourag
competit
patent
publish
whole
world
know
patente
detail
road
map
invent
intend
use
way
leav
door
open
inventor
chang
improv
upon
origin
patent
thu
allow
competit
time
frame
origin
patent
three
base
patent
addon
set
expir
inspir
wealth
innov
put
lf
good
stead
next
year
digit
multiplex
platform
gain
market
penetr
later
flow
limit
compani
start
develop
reader
remov
subject
read
test
strip
also
make
later
flow
simpl
test
use
reader
calibr
way
adapt
later
flow
new
test
need
wo
nt
happen
everi
kind
test
later
flow
best
yesno
type
test
need
quantit
probabl
good
new
technolog
appropri
later
flow
definit
complement
test
modal
chip
biosensor
bead
array
said
rosenstein
small
exampl
innov
new
test
techniqu
underway
shown
